Aldosterone Increases Vascular Permeability in Rat Skin

Cells. 2022 Aug 30;11(17):2707. doi: 10.3390/cells11172707.

Abstract

The aim of this study was to evaluate the effect of acute aldosterone (ALDO) administration on the vascular permeability of skin. ALDO was injected intradermally into rats, and vascular permeability was measured. Eplerenone (EPL), a selective mineralocorticoid receptor (MR) antagonist, was used. Skin biopsies were carried out for immunohistochemical (IHC) staining, and polymerase chain reactions were performed to analyze the expression of MR, 11β-hydroxysteroid dehydrogenase type 2, von Willebrand factor (vWF), vascular endothelial growth factor (VEGF), and zonula occludens 1. Our study showed the presence of MR in the rat skin vasculature for the first time. It was found that ALDO injection resulted in a more than 30% increase in vascular permeability and enhanced the endothelial exocytosis of vWF. The effect of ALDO diminished after EPL administration. An accumulation of vWF and a reduction in VEGF IHC staining were observed following chronic EPL administration. No effect of ALDO or EPL on the mRNA expression of the studied genes or skin structure was observed. The results suggest that ALDO increases vascular permeability in the skin via an MR-dependent mechanism. This effect of ALDO on skin microcirculation may have important therapeutic implications for diseases characterized by increased levels of ALDO and coexisting skin microangiopathy.

Keywords: aldosterone; eplerenone; skin microcirculation; vascular permeability; von Willebrand factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aldosterone* / metabolism
  • Aldosterone* / pharmacokinetics
  • Aldosterone* / pharmacology
  • Animals
  • Capillary Permeability* / drug effects
  • Eplerenone
  • Mineralocorticoid Receptor Antagonists
  • Rats
  • Vascular Endothelial Growth Factor A / metabolism
  • von Willebrand Factor / metabolism

Substances

  • Mineralocorticoid Receptor Antagonists
  • Vascular Endothelial Growth Factor A
  • von Willebrand Factor
  • Aldosterone
  • Eplerenone

Grants and funding

This research was funded by the Medical University of Bialystok (grant number: SUB/2/DN/21/002/2226).